PLCG2 across human disease: genetic variants, signaling mechanisms, and clinical implications
Open Access
- 8 January 2026
- journal article
- review article
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 24 (1)
Abstract
Phospholipase Cγ2 (PLCG2) serves as a central signal transducer within immune and neural lineages, catalyzing the conversion of membrane phosphoinositKeywords
Funding Information
- Shanghai’s Three Year Action Plan for Further Accelerating the Inheritance, Innovation and Development of Traditional Chinese Medicine ((2021-2023) (ZY(2021-2023)-0208 and ZY (2021-2023)-0209-03))
- China Postdoctoral Science Foundation General Program (2024M762083)
- the Traditional Chinese Medicine Research Project of Shanghai Municipal Health Commission (2024QN110)
This publication has 79 references indexed in Scilit:
- PLCG2 modulates TREM2 expression and signaling in response to Alzheimer's disease pathologyAlzheimer's & Dementia, 2025
- Treatment patterns, clinical outcomes and gene mutation characteristics of hepatitis B virus‐associated mantle cell lymphomaHematological Oncology, 2024
- Cognitively healthy centenarians are genetically protected against Alzheimer's diseaseAlzheimer's & Dementia, 2024
- Genomic landscape of follicular lymphoma across a wide spectrum of clinical behaviorsHematological Oncology, 2023
- Heterozygous expression of the Alzheimer’s disease-protective PLCγ2 P522R variant enhances Aβ clearance while preserving synapsesCellular and Molecular Life Sciences, 2022
- The P522R protective variant of PLCG2 promotes the expression of antigen presentation genes by human microglia in an Alzheimer's disease mouse modelAlzheimer's & Dementia, 2022
- Four diseases, PLAID, APLAID, FCAS3 and CVID and one gene (PHOSPHOLIPASE C, GAMMA‐2; PLCG2): Striking clinical phenotypic overlap and differenceClinical Case Reports, 2021
- Neutrophil Phospholipase Cγ2 Drives Autoantibody‐Induced Arthritis Through the Generation of the Inflammatory MicroenvironmentArthritis & Rheumatology, 2021
- Distinct Cutaneous Manifestations and Cold-Induced Leukocyte Activation Associated WithPLCG2MutationsJAMA Dermatology, 2015
- Brief Report: Connecting Two Pathways Through Ca2+ Signaling: NLRP3 Inflammasome Activation Induced by a Hypermorphic PLCG2 MutationArthritis & Rheumatology, 2014